Like Wegovy, Ozempic is a GLP-1 receptor agonist administered once weekly via subcutaneous injection in the abdomen, thigh, or upper arm
Common side effects of tirzepatide include nausea, vomiting, diarrhea, headache, and a potential risk of hypoglycemia
Hormonal profiles and metabolic parameters (GLP-1 and AGEs) were measured in all participants
Beyond GLP-1/GIP dual agonism, triple-hormone receptor agonists such as retatrutide further expand this framework by engaging GIP, GLP-1, and glucagon receptors within a single molecule (109)
Common side effects of Ozempic include nausea, vomiting, and abdominal pain
The Weight Loss Revolution That's Changing Australian Plates Unless you've been living under a rock, you've probably heard about the "miracle" weight loss drugs taking Australia by storm